athenahealth, Inc. Reports Second Quarter Fiscal Year 2015 Results

Go back to athenahealth, Inc. Reports Second Quarter Fiscal Year 2015 Results

Canaccord Genuity Remains Sidelined on Athenahealth, Inc. (ATHN) Following 2Q15

July 27, 2015 9:10 AM EDT

Canaccord Genuity reiterated a Hold rating and $125.00 price target on athenahealth (NASDAQ: ATHN) following 2Q15 results. Analyst Richard Close expects ATHN's differentiated cloud offerings to gain market share as physicians seek cost effective SaaS platforms.

Close commented, "As previously stated, we expect ATHN's differentiated cloud offerings to gain market share as physicians seek to replace 1st... More

Athenahealth, Inc. (ATHN) Tops Q2 EPS by 7c

July 23, 2015 4:02 PM EDT

Athenahealth, Inc. (NASDAQ: ATHN) reported Q2 EPS of $0.32, $0.07 better than the analyst estimate of $0.25. Revenue for the quarter came in at $224.7 million versus the consensus estimate of $226.57 million.

Athenahealth, Inc. sees FY2015 EPS of $1.10-$1.20, versus the consensus of $1.18. Athenahealth, Inc. sees FY2015... More